The Patent Finder

Terms ending in 2041

Cybin UK Ltd.

Every in-force patent on Cybin UK Ltd.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,471,417Deuterated N,n-Dimethyltryptamine Compounds
In force
 · High confidence
Cybin UK Ltd.In forceHigh confidence
US 11,773,062Deuterated Compounds
In force
 · High confidence
Cybin UK Ltd.In forceHigh confidence
US 12,042,564Therapeutic Solid Dosage Forms
In force
 · High confidence
Cybin UK Ltd.In forceHigh confidence
US 12,251,371Deuterated or Partially Deuterated N,n-Dimethyltryptamine Compounds
In force
 · High confidence
Cybin UK Ltd.In forceHigh confidence
US 12,521,370Inhalable Formulations
In force
 · Medium confidence
Cybin UK Ltd.In forceMedium confidence
US 11,697,6385-Methoxy-N,N-DIMETHYLTRYPTAMINE Crystalline Forms
In force
 · High confidence
Cybin UK Ltd.In forceHigh confidence
US 11,660,289Deuterated or Partially Deuterated N,n-Dimethyltryptamine Compounds
In force
 · Medium confidence
Cybin UK Ltd.In forceMedium confidence
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited